Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens
<p>Traditional vaccine development strategies are costly and time-consuming which makes them unsuitable for clinical assessment of new vaccines in the context of infectious diseases outbreaks. Platform technologies provide substantial manufacturing advantages and have the potential to signific...
Hlavní autor: | Moreira Folegatti, P |
---|---|
Další autoři: | Gilbert, S |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
2021
|
Témata: |
Podobné jednotky
-
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
Autor: Adam Berg, a další
Vydáno: (2021-10-01) -
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
Autor: Charlotte Davis, a další
Vydáno: (2024-06-01) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Autor: Zhang, C, a další
Vydáno: (2023) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Autor: Cheng Zhang, a další
Vydáno: (2023-06-01) -
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
Autor: Natalie Gabrielle Marchevsky, a další
Vydáno: (2022-07-01)